Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Urinary Incontinence
Open-data reference.
50 US clinical trials · 18 currently recruiting
Active & Recent Trials
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
NICHD Pelvic Floor Disorders Network
NCT06480227
TReating Incontinence for Underlying Mental and Physical Health
University of California, San Francis
NCT05362292
Training for Urinary Leakage Improvement After Pregnancy
NICHD Pelvic Floor Disorders Network
NCT06411158
NXT Post-Market Clinical Follow-up
Laborie Medical Technologies
NCT06336304
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
Uromedica
NCT04248283
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
University of Rochester
NCT06369922
Effect of Group Preoperative Pelvic Floor Training for HoLEP
University of California, San Francis
NCT05719220
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Northwestern University
NCT05878951
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
Augusta University
NCT05771597
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
BTL Industries
NCT07413705
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women
BTL Industries
NCT07413692
Improving Overactive Bladder Treatment Access and Adherence
Stanford University
NCT06094543
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
The University of Texas Medical Branch, Galveston
NCT04565925
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
Urological Research Network
NCT05698576
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
University of Wisconsin, Madison
NCT06840899
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
VA Office of Research and Development
NCT05141487
Muscle Fiber Fragment Treatment for Urinary Incontinence
Wake Forest University
NCT01953263
rTMS in Overactive Bladder
The Methodist Hospital Research Institute
NCT06198439
Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans
University of Alabama at Birmingham
NCT05438849
A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence
University of California, San Diego
NCT05534412
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
Brigham and Women's Hospital
NCT03522961
Use of Artificial Intelligence by Urogynecologic Patients
Hartford Hospital
NCT06481436
Physical Therapy for Men Undergoing Prostatectomy
Indiana University
NCT02558946
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
The University of Texas Medical Branch, Galveston
NCT05880862
WI-INTUIT: Bridging Community Based Continence Promotion and Primary Care
Medical College of Wisconsin
NCT05664451
Clinical Study of External Electrical Stimulation for Male Incontinence
Elidah
NCT06620419
Use of Sildenafil for Treatment of Urinary Incontinence
The University of Texas Medical Branch, Galveston
NCT02983461
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
Pfizer's Upjohn has merged with Mylan to form Viatris
NCT00147654
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
Duramed Research
NCT00196404
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Ananias Diokno
NCT01479816
Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence
Carelon Research
NCT00064662
Translating Unique Learning for Incontinence Prevention
University of Michigan
NCT01599715
Self-Care to Prevent Birth-Related Urinary Incontinence in Diverse Women
University of Michigan
NCT00763984
Improving Care for Women With Urinary Incontinence (EMPOWER)
University Hospitals Cleveland Medical Center
NCT05515198
A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
Astellas Pharma
NCT00333112
Urge Incontinence Bladder Overactivity Study
Eli Lilly and Company
NCT00475696
Improving Women's Health by Using an Electronic Pelvic Floor Questionnaire
University of Wisconsin, Madison
NCT00880880
An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence
Boston Scientific Corporation
NCT00080470
Pelvic Floor Disorder Assessment of Knowledge and Symptoms: an Educational Model in Spanish-Speaking Women
Johns Hopkins University
NCT04829721
Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery
Yale University
NCT03539107
What is the Impact of the Presence of a Support Person on Informed Consent
Hartford Hospital
NCT03966469
The Urinary Incontinence Treatment Study
Wake Forest University Health Sciences
NCT03057834
TVT-SECUR as an Office-based Procedure
Michigan Institution of Women's Health PC
NCT01137539
Efficacy of rPMS for Improvement of Urinary Incontinence and Female Sexual Function
BTL Industries
NCT03942484
Physical Exercise and Bladder Training Program for Urinary Incontinence
University of Pennsylvania
NCT03869918
Lessening Incontinence by Learning Yoga
University of California, San Francis
NCT01672190
Computerized-Adaptive Testing: Feasibility In Women With Pelvic Floor Disorders (CAT)
Women and Infants Hospital of Rhode Island
NCT01288703
Muscle Progenitor Cell Therapy for Urinary Incontinence
Wake Forest University
NCT01953315
Incontinence Management System ICU Field Evaluation
Hill-Rom
NCT03628833
Mindfulness-Based Stress Reduction Techniques and Yoga for Treatment of Urinary Urge Incontinence (MBSR-Yoga)
University of Utah
NCT01470560
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 4 |
| Phase 2 | 7 |
| Phase 3 | 2 |
| Phase 4 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Urinary Incontinence Trial Landscape
ClinicalTrials.gov lists 50 US studies indexed under Urinary Incontinence, and 18 of those are currently open to recruitment — roughly 36% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Urinary Incontinence shows 5 late-stage studies (Phase 3 and Phase 4 combined) alongside 11 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Urinary Incontinence is led by BTL Industries with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 50 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Urinary Incontinence?
PlainTrial tracks 50 US clinical trials for Urinary Incontinence, of which 18 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Urinary Incontinence?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.